ElectroCore rises on upbeat preliminary results
** Shares of medical device maker electroCore Inc ECOR.O
rise 22.5% to $0.37
** Company expects to report preliminary full-year 2022
revenue of ~$8.5 mln vs analysts' est. of $8.2 mln - Refinitiv
IBES data
** Also anticipates preliminary Q4 revenue of $2.5 mln vs
analysts' est. of $2.2 mln - Refinitiv
** ECOR ended 2022 with ~$18.0 mln in cash and cash
equivalents; it had ~$21.9 mln as of Sept. 30
** Stock lost ~56% in 2022
(Reporting by Sriparna Roy)
((Sriparna.Roy@thomsonreuters.com))
Recent news on electroCore,.
See all newselectroCore reiterates FY 2026 revenue guidance
Brief: electroCore Q1 Net Income USD -5.271 Million
Brief: Electrocore Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: electroCore Says Dan Goldberger To Retire As CEO Effective April 1, 2026
Brief: Electrocore Announces Full Year 2025 Financial Results And Organizational Changes